Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Are you going abroad? Whether you’re travelling for work or pleasure, letting people know about your condition in their native language could save you in an emergency

The ‘PD Doc’ is a free downloadable resource that lets people know about your Parkinson’s disease when you are in a foreign country – it is available in 25 languages, from Chinese to German. In an emergency, it’s important that people are made aware of your condition, so they can get you the right help.

PD Doc languages

This simple document clearly identifies the person with Parkinson’s and their condition, as well as listing emergency contact details.

You can personalise your own PD Doc print out to include several languages. For example, if you are travelling in Switzerland you can print in German, Italian and French.

PD Doc in Croatian

The PD Doc was developed by the European Parkinson’s Disease Association in association with healthcare professionals and industry partners.

The PD Passport is a more advanced version of PD Doc, allowing users to store additional information on medications and therapies.

Download the PD Doc for free here

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Tremor-reducing GyroGlove set to launch in 2017

Volunteer testers wanted as launch date nears

“I came home, spoke to my wife, and we cried together”

Meet the man using poetry to express his feelings about Parkinson’s

Game of Thrones star pedals for Parkinson’s

Enzo Cilenti saddles up with his dad, who has Parkinson's, for fundraising

World War II weapon antidote could treat Parkinson’s

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s. It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease. In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain. Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

Repurposed cancer drug shows promise for Parkinson’s

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive. Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

Research survey assesses impact of holidays on Parkinson’s symptoms

The Radboud University Medical Center, Netherlands, is seeking participants for an online survey assessing the effects of a holiday on Parkinson’s. The study will assess whether a vacation can have physical and mental benefits for people living with the condition. It will also look at which specific factors, such as temperature and physical activity, can alleviate or increase symptoms. The Michael J Fox Foundation has approved the study’s protocol. Participants can sign up to complete the 20-minute survey online. The survey is open to anyone over 18 who has Parkinson’s and has been on vacation once or more between 1 June 2016 and 30 September 2018. Marjan Faber, the study’s daily supervisor, said: “If the study is able to identify decisive factors, those can act as a starting point for novel approaches in care for people with Parkinson’s disease.” To apply please visit research platform ParkinsonNEXT.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Phone
This field is for validation purposes and should be left unchanged.

Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Tremor-reducing GyroGlove set to launch in 2017

Interviews

“I came home, spoke to my wife, and we cried together”

Perspectives

Game of Thrones star pedals for Parkinson’s

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Free multilingual Parkinson’s document helps patients travelling abroad

Resources & Tools

Author: Parkinson's Life editorsPublished: 7 April 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Tremor-reducing GyroGlove set to launch in 2017

Interviews

“I came home, spoke to my wife, and we cried together”

Perspectives

Game of Thrones star pedals for Parkinson’s

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Sign in